Subcutaneous injection of OVA into the sole of the paw causes skin inflammation, with increased levels of interleukins (IL-1beta, IL6, IL13), cytokines (TNF-alpha), and chemokines (CCL11) in the skin of this region [120]. This evidence concerns the gene IL6 and dermatitis.